Hematopoietic stem cell transplantation (HSCT) remains an effective method for treating a
multitude of malignant or nonmalignant disorders. While in autologous HSCT, patients …

Allogeneic stem cell transplant (allo SCT) is a curative treatment for many hematological
malignant and non-malignant diseases and provides a long lifespan. Complications occur …

Hematopoietic cell transplantation (HCT) is used to treat a variety of malignant and
nonmalignant conditions and carries unique toxicities. This chapter provides an overview of …

Hematopoietic stem cell transplantation has evolved into a modern therapeutic modality for
variety of life-threatening hematologie, neoplastic and immunologie diseases. Around the …

Stem cell transplantation of peripheral blood or bone marrow has evolved into an accepted
treatment for a variety of life-threatening hematological, neoplastic, and immunological …

HEMATOPOIETIC STEM CELL TRANSPLANTATION has been used for many years to treat
various malignant and nonmalignant hematologic conditions. However, the high-dose …

With increasing hematopoietic stem cell transplant (HSCT) activity and improvement in
outcomes, there are many thousands of HSCT survivors currently being followed by non …

The use of hematopoietic cell transplantation has expanded and evolved substantially in the
last decade. New stem cell sources and stem cell mobilizing agents have been introduced in …

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective therapy for
various malignant and non-malignant diseases. Many patients have now been followed for …

Background: Fifty years of hematopoietic cell transplantation (HCT) has ushered in an
exciting era of cellular therapy and has led to enormous progress in improving the outcomes …